Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 7/20 | 0.92 |
| ▸ | CNR1 | P21554 | 2/20 | 0.92 |
| ▸ | CNR2 | P34972 | 2/20 | 0.92 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.92 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.92 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.92 |
| ▸ | INHA | P05111 | 1/20 | 0.92 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.92 |
| ▸ | HTR2A | P28223 | 1/20 | 0.92 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.92 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.92 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.92 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.92 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.92 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.92 |
| ▸ | TRPV2 | Q9Y5S1 | 1/20 | 0.92 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.63 |
| ▸ | BACE1 | P56817 | 1/20 | 0.63 |
| ▸ | TRPM7 | Q96QT4 | 1/20 | 0.58 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23523476 | 1.00 | PPARG (0.92) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| Cannabigerol SCHEMBL12954626 | 0.96 | PPARG (1.00) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| Cannabigerol SCHEMBL144819 | 0.96 | PPARG (1.00) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| Cannabigerol SCHEMBL14764730 | 0.96 | PPARG (1.00) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523642 | 0.95 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23522969 | 0.95 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523554 | 0.95 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523040 | 0.95 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523558 | 0.95 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23522965 | 0.95 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250263761-A1 | PRODUCTION OF CANNABINOIDS/PHYTOCANNABINOIDS WITH A PLANT EXTRACT | Technische Universität Darmstadt (DE) | 2025-08-21 | — | — | US | disclosed |
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |
| US-20230375561-A1 | METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES | KADDURAH DAOUK RIMA F (US) | 2023-11-23 | — | — | US | disclosed |
| US-11801278-B2 | Method for obtaining an extract of a plant biomass | CUREX PHARMACEUTICAL MEXICO S.A.P.I. DE C.V. (MX) | 2023-10-31 | — | — | US | disclosed |
| US-11801278-B2 | Method for obtaining an extract of a plant biomass | CUREX PHARMACEUTICAL MEXICO S.A.P.I. DE C.V. (MX) | 2023-10-31 | — | — | US | disclosed |
| EP-4244371-A1 | PRODUCTION OF CANNABINOIDS/PHYTOCANNABINOIDS WITH A PLANT EXTRACT | Technische Universität Darmstadt (DE) | 2023-09-20 | — | — | EP | disclosed |
| US-20230226144-A1 | TOPICAL ANTIBIOTIC | CONCEPT MATRIX SOLUTIONS (US) | 2023-07-20 | — | — | US | disclosed |
| US-20230172846-A1 | ORAL DISSOLVABLE FILM AND METHOD OF MANUFACTURING AND USING THE SAME | CUREX PHARMACEUTICAL MEXICO S.A.P.I. DE C.V. (MX) | 2023-06-08 | — | — | US | disclosed |
| US-20230172846-A1 | ORAL DISSOLVABLE FILM AND METHOD OF MANUFACTURING AND USING THE SAME | CUREX PHARMACEUTICAL MEXICO S.A.P.I. DE C.V. (MX) | 2023-06-08 | — | — | US | disclosed |
| US-20230165807-A1 | COMPOSITIONS INCLUDING TERPENES, CANNABINOID OILS, OR FLAVONOIDS AND USES THEREOF | CALIBRATED THERAPEUTICS, LLC | 2023-06-01 | — | — | US | disclosed |
| US-20210093529-A1 | TOPICAL SUNSCREEN | CONCEPT MATRIX SOLUTIONS | 2021-04-01 | — | — | US | disclosed |
| US-20210093724-A1 | TOPICAL ANTI-ACNE COMPOSITION | CONCEPT MATRIX SOLUTIONS | 2021-04-01 | — | — | US | disclosed |
| US-20210093539-A1 | TOPICAL COSMETIC | CONCEPT MATRIX SOLUTIONS | 2021-04-01 | — | — | US | disclosed |
| US-20210015836-A1 | TOPICAL ANALGESIC | CONCEPT MATRIX SOLUTIONS | 2021-01-21 | — | — | US | disclosed |
| US-20200093075-A1 | BIOCERAMIC AND CARBON-BASED HYDROPONIC SYSTEMS, METHODS AND DEVICES | MULTIPLE ENERGY TECHNOLOGIES LLC | 2020-03-26 | — | — | US | disclosed |
| US-10368502-B2 | Bioceramic and carbon-based hydroponic systems, methods and devices | MULTIPLE ENERGY TECHNOLOGIES LLC (US) | 2019-08-06 | — | — | US | disclosed |
| WO-2019060849-A1 | BIOCERAMIC AND CARBON-BASED HYDROPONIC SYSTEMS, METHODS AND DEVICES | MULTIPLE ENERGY TECHNOLOGIES LLC (US) | 2019-03-28 | — | — | WO | disclosed |
| US-20190090438-A1 | BIOCERAMIC AND CARBON-BASED HYDROPONIC SYSTEMS, METHODS AND DEVICES | MULTIPLE ENERGY TECHNOLOGIES LLC | 2019-03-28 | — | — | US | disclosed |
| US-20170283837-A1 | BIOENZYMATIC SYNTHESIS OF THC-v, CBV AND CBN AND THEIR USE AS THERAPEUTIC AGENTS | TUATARA CAPITAL FUND I, L.P. | 2017-10-05 | — | — | US | disclosed |
| US-20170283837-A1 | BIOENZYMATIC SYNTHESIS OF THC-v, CBV AND CBN AND THEIR USE AS THERAPEUTIC AGENTS | TUATARA CAPITAL FUND I, L.P. | 2017-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230165807-A1 | COMPOSITIONS INCLUDING TERPENES, CANNABINOID OILS, OR FLAVONOIDS AND USES THEREOF | CNR2, CNR1, FAAH | PPARG 9/4885CNR1 2/4885CNR2 1/4885 |
| US-20190090438-A1 | BIOCERAMIC AND CARBON-BASED HYDROPONIC SYSTEMS, METHODS AND DEVICES | CNR2, GAP43, CNR1 | PPARG 1768/4885CNR1 3/4885CNR2 1/4885 |
| US-20200093075-A1 | BIOCERAMIC AND CARBON-BASED HYDROPONIC SYSTEMS, METHODS AND DEVICES | CNR2, GAP43, CNR1 | PPARG 1768/4885CNR1 3/4885CNR2 1/4885 |
| US-20230226144-A1 | TOPICAL ANTIBIOTIC | CUTA, CNR2, CNR1 | PPARG 101/4885CNR1 3/4885CNR2 2/4885 |
| US-20210093724-A1 | TOPICAL ANTI-ACNE COMPOSITION | CUTA, EBP, CNR2 | PPARG 5/4885CNR1 4/4885CNR2 3/4885 |
| US-20210093529-A1 | TOPICAL SUNSCREEN | SUN2, CYP51A1, DSG1 | PPARG 136/4885CNR1 20/4885CNR2 10/4885 |
| US-20210015836-A1 | TOPICAL ANALGESIC | TRPV1, CNR2, FAAH | PPARG 239/4885CNR1 5/4885CNR2 2/4885 |
| US-20230172846-A1 | ORAL DISSOLVABLE FILM AND METHOD OF MANUFACTURING AND USING THE SAME | DSTN, FDFT1, DDHD2 | PPARG 4608/4885CNR1 2006/4885CNR2 1321/4885 |
| US-20170283837-A1 | BIOENZYMATIC SYNTHESIS OF THC-v, CBV AND CBN AND THEIR USE AS THERAPEUTIC AGENTS | CNR1, CNR2, BCHE | PPARG 1361/4885CNR1 1/4885CNR2 2/4885 |
| US-11801278-B2 | Method for obtaining an extract of a plant biomass | DDOST, FDFT1, ALG8 | PPARG 253/4885CNR1 1537/4885CNR2 973/4885 |
| US-10368502-B2 | Bioceramic and carbon-based hydroponic systems, methods and devices | CNR2, GAP43, CNR1 | PPARG 1768/4885CNR1 3/4885CNR2 1/4885 |
| US-20210093539-A1 | TOPICAL COSMETIC | CUTA, CNR2, DSG1 | PPARG 13/4885CNR1 6/4885CNR2 2/4885 |
| US-20230375561-A1 | METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES | SLC25A20, CPT2, NDUFAB1 | PPARG 567/4885CNR1 106/4885CNR2 91/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.